Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Glory View Technology
301396
4
Guangzhou Sie Consulting
300687
5
Tibet Duo Rui Pharmaceutical
301075
US Stock MarketDetailed Quotes
MDWD MediWound
- 15.520
- -0.430-2.70%
Close Mar 31 16:00 ET
- 15.600
- +0.080+0.52%
Post 18:16 ET
174.63MMarket Cap-5.12P/E (TTM)
16.140High14.710Low130.13KVolume15.900Open15.950Pre Close1.99MTurnover1.68%Turnover RatioLossP/E (Static)11.25MShares24.00052wk High5.60P/B120.54MFloat Cap12.78052wk Low--Dividend TTM7.77MShs Float135.170Historical High--Div YieldTTM8.97%Amplitude7.100Historical Low15.267Avg Price1Lot Size
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
MediWound Stock Forum
MediWound Delivers Record Revenue Growth: NexoBrid Sales Soar 42% Amid Major Funding Wins
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
Tuesday, 17th December at 8:00 am
YAVNE, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced it will host a virtual Key Opinion Leader (KOL) event on Wednesday, January 8, 2025, at 10:00 AM ET. T...
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet